Glioneuronal Tumors: Clinicopathological Findings and Treatment Options

References

• BratDJ, PerryA. Neuronal and glioneuronal neoplasms. Practical Surgical Neuropathology: A Diagnostic Approach (2nd Edition).Elsevier, Amsterdam, The Netherlands, 183–217 (2008).
   Google Scholar
• LouisDN, PerryA, ReifenbergerGet al.The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol.131(6), 803–820 (2016).
   PubMed Web of Science ®Google Scholar
• LucasCG, Villanueva-MeyerJE, WhippleNet al.Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathol.30(3), 479–494 (2019)
   PubMed Web of Science ®Google Scholar
• YamadaS, NobusawaS, YamazakiTet al.An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation. Pathol. Int.69(6), 372–377 (2019).
   PubMed Web of Science ®Google Scholar
• PekmezciM, Villanueva-MeyerJE, GoodeBet al.The genetic landscape of ganglioglioma. Acta Neuropathol. Commun.6(1), 47 (2018).
   PubMedGoogle Scholar
• TomitaT, VolkJM, ShenW, PundyT. Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences. Childs Nerv. Syst.32(10), 1839–1848 (2016).
   PubMed Web of Science ®Google Scholar
• LuykenC, BlümckeI, FimmersR, UrbachH, WiestlerOD, SchrammJ. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer101(1), 146–155 (2004).
   PubMed Web of Science ®Google Scholar
• Kalyan-RamanUP, OliveroWC. Ganglioglioma: a correlative clinico- pathological and radiological study of ten surgically treated cases with follow-up. Neurosurgery20(3), 428–433 (1987).
   PubMed Web of Science ®Google Scholar
• PanditaA, BalasubramaniamA, PerrinR, ShannonP, GuhaA. Malignant and benign ganglioglioma: a pathological and molecular study. Neuro-oncol.9(2), 124–134 (2007).
   PubMed Web of Science ®Google Scholar
• DemierreB, StichnothFA, HoriA, SpoerriO. Intracerebral ganglioglioma. J. Neurosurg.65(2), 177–182 (1986).
   PubMed Web of Science ®Google Scholar
• BlümckeI, WiestlerOD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J. Neuropathol. Exp. Neurol.61(7), 575–584 (2002).
   PubMed Web of Science ®Google Scholar
• UlutinHC, ÖngürüO, PakY. Postoperative radiotherapy for gangli- oglioma; report of three cases and review of the literature. Minim. Invasive Neurosurg.45(4), 224–227 (2002).
   PubMedGoogle Scholar
• ImSH, ChungCK, ChoBKet al.Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J. Neurooncol.59(2), 173–183 (2002).
   PubMed Web of Science ®Google Scholar
• JanjuaMB, IvasykI, PisapiaDJ, SouweidaneMM. Ganglioglioma of brain stem and cervicomedullary junction: a 50 years review of literature. J. Clin. Neurosci.44, 34–46 (2017).
   PubMed Web of Science ®Google Scholar
• WalkerDA, LiuJ, KieranMet al.A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro Oncol.15(4), 462–468 (2013).
   PubMed Web of Science ®Google Scholar
• TomaselloC, FranceschiE, TosoniA, BrandesA. Gangliogliomas: recent advances in classification and treatment. Future Neurol.5(4), 557–568 (2010).
   Google Scholar
• PasquierB, PéocHM, Fabre-BocquentinBet al.Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord.4(2), 99–119 (2002).
   PubMed Web of Science ®Google Scholar
• LuykenC, BlumckeI, FimmersR, UrbachH, WiestlerOD, SchrammJ. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer101(1), 146–155 (2004).
   PubMed Web of Science ®Google Scholar
• JalloGI, FreedD, EpsteinFJ. Spinal cord gangliogliomas: a review of 56 patients. J. Neurooncol.68(1), 1–77 (2004).
   PubMed Web of Science ®Google Scholar
• ChappeC, PadovaniL, ScavardaDet al.Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol.23(5), 574–583 (2013).
   PubMed Web of Science ®Google Scholar
• ChenX, PanC, ZhangPet al.BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas. J. Clin. Neurosci.46, 50–57 (2017).
   PubMed Web of Science ®Google Scholar
• DahiyaS, HaydonDH, AlvaradoD, GurnettCA, GutmannDH, LeonardJR. BRAF(V600E) mutation is a negative prognosticator in pediatricganglioglioma. Acta Neuropathol.125(6), 901–910 (2013).
   PubMed Web of Science ®Google Scholar
• DonsonAM, Kleinschmidt-DeMastersBK, AisnerDLet al.Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases. Brain Pathol.24(2), 173–183 (2014).
   PubMed Web of Science ®Google Scholar
• GessiM, DörnerE, DreschmannVet al.Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases. Hum. Pathol.49, 107–113 (2016).
   PubMed Web of Science ®Google Scholar
• GuptaK, OrismeW, HarreldJHet al.Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups. Acta Neuropathol. Commun.2, 18 (2014).
   PubMed Web of Science ®Google Scholar
• SchindlerG, CapperD, MeyerJet al.Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol.121(3), 397–405 (2011).
   PubMed Web of Science ®Google Scholar
• ZhangJ, WuG, MillerCPet al.Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat. Genet.45(6), 602–612 (2013).
   PubMed Web of Science ®Google Scholar
• PagesM, BeccariaK, BoddaertNet al.Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol.28(1), 103–111 (2018).
   PubMed Web of Science ®Google Scholar
• LouisDN, GianniniC, CapperDet al.cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-Mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol.135(4), 639–642 (2018).
   PubMed Web of Science ®Google Scholar
• BridgeJA, LiuXQ, SumegiJet al.Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol.23(2), 121–128 (2013).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network, BratDJ, VerhaakRGet al.Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med.372(26), 2481–2498 (2015).
   PubMed Web of Science ®Google Scholar
• PrabowoAS, IyerAM, VeersemaTJet al.BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol.24(1), 52–66 (2014).
   PubMed Web of Science ®Google Scholar
• LassalettaA, ZapotockyM, MistryMet al.Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J. Clin. Oncol.35(25), 2934–2941 (2017).
   PubMed Web of Science ®Google Scholar
• ZentnerJ, WolfHK, OstertunBet al.Gangliogliomas: clinical, radiological and histopathological findings in 51 patients. J. Neurol. Neurosurg. Psychiatry57(12), 1497–1502 (1994).
   PubMed Web of Science ®Google Scholar
• DemirMK, YapicierO, YilmazB, KiliçT. Magnetic resonance imaging findings of mixed neuronal-glial tumors with pathologic correlation: a review. Acta Neurol. Belg.118(3), 379–386 (2018).
   PubMed Web of Science ®Google Scholar
• BaltuchGH, FarmerJP, Meagher-VillemureK, MontesJL, O'GormanAM. Ganglioglioma presenting as a vascular lesion in a 10-year old boy. Case report. J. Neurosurg.79(6), 920–923 (1993).
   PubMed Web of Science ®Google Scholar
• MillerDC, LangFF, EpsteinFJ. Central nervous system gangliogliomas. Part 1: pathology. J. Neurosurg.79(6), 859–866 (1993).
   PubMed Web of Science ®Google Scholar
• MatsumotoK, TamiyaT, OnoT, FurutaS, AsariS, OhmotoT. Cerebral gangliogliomas: clinical characteristics, CT and MRI. Acta Neurochir.141(2), 135–141 (1999).
   PubMed Web of Science ®Google Scholar
• StoklandT, LiuJF, IronsideJWet al.A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol.12(12), 1257–1268 (2010).
   PubMed Web of Science ®Google Scholar
• TerashimaK, ChowK, JonesJet al.Long-term outcome of centrally located low-grade glioma in children. Cancer119(14), 2630–2638 (2013).
   PubMed Web of Science ®Google Scholar
• SelchMT, GoyBW, LeeSPet al.Gangliogliomas: experience with 34 patients and review of the literature. Am. J. Clin. Oncol.21(6), 557–564 (1998).
   PubMed Web of Science ®Google Scholar
• PackerRJ. Radiation therapy for pediatric low-grade gliomas: survival and sequelae. Curr. Neurol. Neurosci. Rep.10(1), 10–13 (2010).
   PubMedGoogle Scholar
• MerchantTE, KunLE, WuS, XiongX, SanfordRA, BoopFA. Phase II trial of conformal radiation therapy for pediatric low-grade gliomas. J. Clin. Oncol.27(22), 3598–3604 (2009).
   PubMed Web of Science ®Google Scholar
• RadesD, ZwickL, LeppertJet al.The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer116(2), 432–442 (2010).
   PubMed Web of Science ®Google Scholar
• SoffiettiR, RudàR, ReardonD. Rare glial tumors. In: Handbook of Clinical Neurology, Vol 134 (3^rd Series).BergerMS, WellerM ( Eds). Elsevier, Amsterdam, The Netherlands, 399–415 (2016).
   Google Scholar
• LiauwSL, ByerJE, YachnisAT, AmdurRJ, MendenhallWM. Radiotherapy after subtotally resected or recurrent ganglioglioma. Int. J. Radiat. Oncol. Biol. Phys.67(1), 244–247 (2007).
   PubMed Web of Science ®Google Scholar
• MohileN, RaizerJJ. Chemotherapy for glioneuronal tumors. In: Handbook of Brain Tumor Chemotherapy.NewtonHB ( Ed.). Elsevier, Amsterdam, The Netherlands, 432–438 (2006).
   Google Scholar
• ChapmanPB, HauschildA, RobertCet al.Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med.364(26), 2507–2516 (2011).
   PubMed Web of Science ®Google Scholar
• RushS, ForemanN, LiuA. Brainstem ganglioglioma successfully treated with vemurafenib. J. Clin. Oncol.31(10), e159–e160 (2013).
   PubMed Web of Science ®Google Scholar
• AguileraD, JanssA, MazewskiCet al.Successful retreatment of a child with a refractory brainstem ganglioglioma with vemurafenib. Pediatr. Blood Cancer63(3), 541–543 (2015).
   PubMed Web of Science ®Google Scholar
• ChamberlainMC. Recurrent ganglioglioma in adults treated with BRAF inhibitors. CNS Oncol.5(1), 27–29 (2016).
   PubMedGoogle Scholar
• DelBufalo F, CaraiA, Figà-TalamancaLet al.Response of recurrent BRAF V600E mutated ganglioglioma to Vemurafenib as single agent. J. Transl. Med.12, 356 (2014).
   PubMed Web of Science ®Google Scholar
• ShihKC, ShastryM, WilliamsJTet al.Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma. J. Clin. Oncol.32(29), e98–e100 (2014).
   PubMed Web of Science ®Google Scholar
• GarnierL, DucrayF, VerlutCet al.Prolonged response induced by single agent vemurafenib in a BRAF V600E spinal ganglioglioma: a case report and review of the literature. Front. Oncol.9, 177 (2019).
   PubMed Web of Science ®Google Scholar
• PasqualettiF, GonnelliA, MolinariAet al.Treatment with dabrafenib in a patient with BRAF mutated recurrent ganglioglioma. Neuro Oncol.20(Suppl. 3), iii258 (2018).
   Google Scholar
• LucasJTJr, HuangAJ, MottRT, LesserGJ, TatterSB, ChanMD. Anaplastic ganglioglioma: a report of three cases and review of literature. J. Neuro Oncol.123(1), 171–177 (2015).
   PubMed Web of Science ®Google Scholar
• MatsuzakiK, UnoM, KagejiT, HiroseT, NagahiroS. Anaplastic ganglioglioma of the cerebellopontine angle. Case report. Neurol. Med. Chir.45(11), 591–595 (2005).
   PubMed Web of Science ®Google Scholar
• BelandB, TsangRY, SutherlandG. Unprecedented response to combination BRAF and MEK inhibitors in adult anaplastic ganglioglioma. J. Neurooncol.137(3), 667–669 (2018).
   PubMed Web of Science ®Google Scholar
• KaleyT, TouatM, SubbiahVet al.BRAF Inhibition in BRAFV600.Mutant Gliomas: results from the VE-BASKET Study. J. Clin. Oncol.36(35), 3477–3484 (2018).
   PubMed Web of Science ®Google Scholar
• MarksAM, BindraRS, DiLunaMLet al.Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib. Pediatr. Blood Cancer65(5), e26969 (2018).
   PubMed Web of Science ®Google Scholar
• TollSA, TranHN, CotterJet al.Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. Oncotarget10(4), 551–557 (2019).
   PubMedGoogle Scholar
• MarksAM, BindraRS, DiLunaMLet al.Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib. Pediatr. Blood Cancer65(5), e26969 (2018).
   PubMed Web of Science ®Google Scholar
• KoelscheC, WohrerA, JeibmannAet al.Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol.125(6), 891–900 (2013).
   PubMed Web of Science ®Google Scholar
• SelvanathanSK, HammoucheS, SalminenHJ, JenkinsonMD. Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database. J. Neurooncol.105(3), 539–545 (2011).
   PubMed Web of Science ®Google Scholar
• SasakiA, HiratoJ, NakazatoY, TamuraM, KadowakiH. Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report. J. Neurosurg.84(6), 1055–1059 (1996).
   PubMed Web of Science ®Google Scholar
• MittlerMA, WaltersBC, FriedAH, SotomayorEA, StopaEG. Malignant glial tumor arising from the site of a previous hamartoma/ganglioglioma: coincidence or malignant transformation?Pediatr. Neurosurg.30(3), 132–134 (1999).
   PubMed Web of Science ®Google Scholar
• KurianNI, NairS, RadhakrishnanVV. Anaplastic ganglioglioma: case report and review of the literature. Br. J. Neurosurg.12(3), 277–280 (1998).
   PubMed Web of Science ®Google Scholar
• CamposMG, ZentnerJ, OstertunB, WolfHK, SchrammJ. Anaplastic ganglioglioma: case report and review of the literature. Neurol. Res.16(4), 317–320 (1994).
   PubMed Web of Science ®Google Scholar
• WhittleIR, MitchenerA, AtkinsonHD, WhartonSB. Anaplastic progression in low grade glioneural neoplasms. Acta Neuropathol.104(2), 215 (2002).
   PubMed Web of Science ®Google Scholar
• DanjouxM, SabatierJ, Uro-CosteE, RocheH, DelisleMB. Anaplastic temporal ganglioglioma with spinal metastasis. Ann. Pathol.21(1), 55–58 (2001).
   PubMed Web of Science ®Google Scholar
• KarremannM, PietschT, JanssenG, KrammCM, WolffJE. Anaplastic gaglioglioma in children. J. Neuro Oncol.92(2), 157–163 (2009).
   PubMed Web of Science ®Google Scholar
• DeMarchiR, Abu-AbedS, MunozD, LochMacdonald R. Malignant ganglioglioma: case report and review of literature. J. Neuro Oncol.101(2), 311–318 (2010).
   PubMed Web of Science ®Google Scholar
• KarabekirHS, BalciC, TokyolC. Primary spinal anaplastic ganglioglioma. Pediatr. Neurosurg.42(6), 374–378 (2006).
   PubMed Web of Science ®Google Scholar
• TerrierM, BauchetL, RigauVet al.Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro Oncol.19(5), 678–688 (2017).
   PubMed Web of Science ®Google Scholar
• MallickS, BensonR, MelgandiW, GiridharP, RathGK. Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma. Childs Nerv. Syst.34(6), 1207–1213 (2018).
   PubMed Web of Science ®Google Scholar
• Daumas-DuportC, ScheithauerBW, ChodkiewiczJP, LawsERJr, VedrenneC. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery23(5), 545–556 (1988).
   PubMed Web of Science ®Google Scholar
• PraysonRA, EstesML. Dysembryoplastic neuroepithelial tumor. Am. J. Clin. Pathol.97(3), 398–401 (1992).
   PubMed Web of Science ®Google Scholar
• HonovarM, JanotaI. 73 cases of dysembryoplastic neuroepithelial tumor: the range of histological appearance. Brain Pathol.4, 428–435 (1994).
   Google Scholar
• Daumas-DuportC, VarletP, BachaS, BeuvonF, Cervera-PierotP, ChodkiewiczJP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms – a study of 40 cases. J. Neuro Oncol.41(3), 267–280 (1999).
   PubMed Web of Science ®Google Scholar
• BodiI, SelwayR, BannisterPet al.Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma. Neuropathol. Appl. Neurobiol.38(5), 411–425 (2012).
   PubMed Web of Science ®Google Scholar
• PraysonRA. Diagnostic challenges in the evaluation of chronic epilepsy-related surgical neuropathology. Am. J. Surg. Pathol.34(5), e1–e13 (2010).
   PubMed Web of Science ®Google Scholar
• StanescuCR, VarletP, BeuvonFet al.Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J. Neuroradiol.28(4), 230–240 (2001).
   PubMed Web of Science ®Google Scholar
• ChappC, PadovaniL, ScavardaDet al.Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol.23(5), 574–583 (2013).
   PubMed Web of Science ®Google Scholar
• LuzziS, EliaA, DelMaestro Met al.Dysembryoplastic neuroepithelial tumors: what you need to know. World Neurosurg.127, 255–265 (2019).
   PubMed Web of Science ®Google Scholar
• BilginerB, YalnizogluD, SoylemezogluFet al.Surgery for epilepsy in children with dysembryoplastic neuroepithelial tumor: clinical spectrum, seizure outcome, neuroradiology, and pathology. Childs Nerv. Syst.25(4), 485–491 (2009).
   PubMed Web of Science ®Google Scholar
• ChangEF, ChristieC, SullivanJEet al.Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J. Neurosurg. Pediatr.5(1), 123–130 (2010).
   PubMed Web of Science ®Google Scholar
• ChassouxF, RodrigoS, MellerioCet al.Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology79(16), 1699–1707 (2012).
   PubMed Web of Science ®Google Scholar
• KimDG, ParkCK. Central neurocytoma: establishment of the disease entity. Neurosurg. Clin. N. Am.26(1), 1–4 (2015).
   PubMed Web of Science ®Google Scholar
• CocaS, MorenoM, MartosJA, RodriguezJ, BarcenaA, VaqueroJ. Neurocytoma of spinalcord. Acta Neuropathol.87(5), 537–540 (1994).
   PubMedGoogle Scholar
• Figarella-BrangerD, SoylemezogluF, HassounJ. Central neurocytoma. In: Pathology and Genetics of Tumors of the Nervous System.Kleihues P, Cavenee WK ( Eds). IARC Press, Lyon, France, 107–109 (2000).
   Google Scholar
• HassounJ, SöylemezogluF, GambarelliD, Figarella-BrangerD, von AmmonK, KleihuesP. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol.3(3), 297–306 (1993).
   PubMed Web of Science ®Google Scholar
• KimDG, ChiJG, ParkSHet al.Intraventricular neurocytoma: clinicopathological analysis of seven cases. J. Neurosurg.76(5), 759–765 (1992).
   PubMed Web of Science ®Google Scholar
• MaiuriF, SpazianteR, DeCaro ML, CappabiancaP, GiamundoA, IaconettaG. Central neurocytoma: clinico-pathological study of 5 cases and review of the literature. Clin. Neurol. Neurosurg.97(3), 219–228 (1995).
   PubMed Web of Science ®Google Scholar
• SharmaMC, DebP, SharmaS, SarkarC. Neurocytoma: a comprehensive review. Neurosurg. Rev.29(4), 270–285 (2006).
   PubMed Web of Science ®Google Scholar
• KulkarniV, RajshekharV, HaranRP, ChandiSM. Long-term outcome in patients with central neurocytoma following stereotactic biopsy and radiation therapy. Br. J. Neurosurg.16(2), 126–132 (2002).
   PubMed Web of Science ®Google Scholar
• SharmaMC, RathoreA, KarakAK, SarkarC. A study of proliferative markers in central neurocytoma. Pathology30(4), 355–359 (1998).
   PubMed Web of Science ®Google Scholar
• SharmaMC, SarkarC, KarakAK, GaikwadS, MahapatraAK, MehtaVS. Intraventricular neurocytoma: a clinicopathological study of 20 cases with review of the literature. J. Clin. Neurosci.6(4), 319–323 (1999).
   PubMed Web of Science ®Google Scholar
• ImberBS, BraunsteinSE, WuFYet al.Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J. Neurooncol.126(1), 193–200 (2016).
   PubMed Web of Science ®Google Scholar
• ChenCL, ShenCC, WangJ, LuCH, LeeHT. Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin. Neurol. Neurosurg.110(2), 129–136 (2008).
   PubMed Web of Science ®Google Scholar
• LeeSJ, BuiTT, ChenCHJet al.Central neurocytoma: a review of clinical management and histopathologic features. Brain Tumor Res. Treat.4(2), 49–57 (2016).
   PubMedGoogle Scholar
• ZhangD, WenL, HenningTDet al.Central neurocytoma: clinical, pathological and neuroradiological findings. Clin. Radiol.61(4), 348–357 (2006).
   PubMed Web of Science ®Google Scholar
• SmithAB, SmirniotopoulosJG, Horkanyne-SzakalyI. From the radiologic pathology archives: intraventricular neoplasms: radiologic-pathologic correlation. Radiographics33(1), 21–43 (2013).
   PubMed Web of Science ®Google Scholar
• WangM, JiaD, ShenJ, ZhangJ, LiG. Clinical and imaging features of central neurocytomas. J. Clin. Neurosci.20(5), 679–685 (2013).
   PubMed Web of Science ®Google Scholar
• BrandesAA, AmistàP, GardimanMet al.Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer88(1), 169–174 (2000).
   PubMed Web of Science ®Google Scholar
• JohnsonMO, KirkpatrickJP, PatelMPet al.The role of chemotherapy in the treatment of central neurocytoma. CNS Oncol.8(3), CNS41 (2019).
   PubMedGoogle Scholar
• MrakRE. Malignant neurocytic tumor. Hum. Pathol.25(8), 747–752 (1994).
   PubMed Web of Science ®Google Scholar
• EnamSA, RosemblumML, HoKL. Neurocytoma in the cerebellum. Case report. J. Neurosurg.87(1), 100–102 (1997).
   PubMed Web of Science ®Google Scholar
• GiangasperoF, CenacchiG, LosiL, CerasoliS, BiscegliaM, BurgerPC. Extraventricular neoplasms with neurocytoma features: a clinicopathological study of 11 cases. Am. J. Surg. Pathol.21(2), 206–212 (1996).
   Web of Science ®Google Scholar
• BratDJ, ScheithauerBW, EberhartCG, BurgerPC. Extraventricular neurocytomas. Pathological features and clinical outcome. Am. J. Surg. Pathol.25(10), 1252–1260 (2001).
   PubMed Web of Science ®Google Scholar
• GardimanMP, FassanM, OrvietoEet al.Diffuse leptomeningeal glioneuronal tumors: a new entity?Brain Pathol.20(2), 361–366 (2010).
   PubMed Web of Science ®Google Scholar
• RodriguezFJ, PerryA, RosenblumMKet al.Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol.124(5), 627–641 (2012).
   PubMed Web of Science ®Google Scholar
• HuseJT, EdgarM, HallidayJ, MikolaenkoI, LaviE, RosenblumMK. Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol.23(5), 515–524 (2013).
   PubMed Web of Science ®Google Scholar
• RodriguezFJ, SchniederjanMJ, NicolaidesT, TihanT, BurgerPC, PerryA. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma- like leptomeningeal neoplasms (DOLN). Acta Neuropathol.129(4), 609–610 (2015).
   PubMed Web of Science ®Google Scholar
• LyleMR, DoliaJN, FratkinJ, NicholsTA, HerringtonBL. Newly identified characteristics and suggestions for diagnosis and treatment of diffuse leptomeningeal glioneuronal/neuroepithelial tumors: a case report and review of the literature. Child Neurol. Open2(1), 1–7 (2015).
   PubMedGoogle Scholar
• HakanT, AkerFV. Rosette-forming glioneuronal tumour of the fourth ventricle: case report and review of the literature. Folia Neuropathol.54(1), 80–87 (2016).
   PubMed Web of Science ®Google Scholar
• AllinsonKS, O'DonovanDG, JenaR, CrossJJ, SantariusTS. Rosette-forming glioneuronal tumor with dissemination throughout the ventricular system: a case report. Clin. Neuropathol.34(2), 64–69 (2015).
   PubMed Web of Science ®Google Scholar
• AllendeDS, PraysonRA. The expanding family of glioneuronal tumors. Adv. Anat. Pathol.16(1), 33–39 (2009).
   PubMed Web of Science ®Google Scholar
• KomoriT, ScheithauerBW, SungJH. Rosette-forming mixed neuronal-glial tumour in the fourth ventricle. Neuropathol. Exp. Neurol.57, 520 (1998).
   Web of Science ®Google Scholar
• ScheithauerBW, SilvaAI, KetterlingRP, PulaJH, LiningerJF, KrinockMJ. Rosette-forming glioneuronal tumor: report of a chiasmal-optic nerve example in neurofibromatosis type 1: special pathology report. Neurosurgery64(4), E771–E772 (2009).
   PubMed Web of Science ®Google Scholar
• AnanM, InoueR, IshiiKet al.A rosette-forming glioneuronal tumor of the spinal cord: the first case of a rosette-forming glioneuronal tumor originating from the spinal cord. Hum. Pathol.40(6), 898–901 (2009).
   PubMed Web of Science ®Google Scholar
• GhosalN, FurtadoSV, HegdeAS. Rosette forming glioneuronal tumor pineal gland and tectum: an intraoperative diagnosis on smear preparation. Diagn. Cytopathol.38(8), 590–593 (2010).
   PubMed Web of Science ®Google Scholar
• FrydenbergE, LahertyR, RodriguezM, Ow-YangM, SteelT. A rosette-forming glioneuronal tumour of the pineal gland. J. Clin. Neurosci.17(10), 1326–1328 (2010).
   PubMed Web of Science ®Google Scholar
• HakanT, AkerFV. Rosette-forming glioneuronal tumour of the fourth ventricle: case report and review of the literature. Folia Neuropathol.54(1), 80–87 (2016).
   PubMed Web of Science ®Google Scholar
• KomoriT, ScheithauerBW, HiroseT. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?Am. J. Surg. Pathol.26(5), 582–591 (2002).
   PubMed Web of Science ®Google Scholar
• EllezamB, TheelerBJ, LuthraR, AdesinaAM, AldapeKD, GilbertMR. Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor. Acta Neuropathol.123(2), 285–287 (2012).
   PubMed Web of Science ®Google Scholar
• GessiM, MoneimYA, HammesJet al.FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle. J. Neuropathol. Exp. Neurol.73(6), 580–584 (2014).
   PubMed Web of Science ®Google Scholar
• JacquesTS, EldridgeC, PatelAet al.Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol. Appl. Neurobiol.32(2), 217–220 (2006).
   PubMed Web of Science ®Google Scholar